Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-3-10
pubmed:abstractText
Tenecteplase is a modified tissue plasminogen activator with a longer half-life and higher fibrin specificity than alteplase.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
915-21
pubmed:meshHeading
pubmed-meshheading:19273826-Aged, pubmed-meshheading:19273826-Brain Ischemia, pubmed-meshheading:19273826-Cerebral Angiography, pubmed-meshheading:19273826-Cerebrovascular Circulation, pubmed-meshheading:19273826-Dose-Response Relationship, Drug, pubmed-meshheading:19273826-Female, pubmed-meshheading:19273826-Humans, pubmed-meshheading:19273826-Image Processing, Computer-Assisted, pubmed-meshheading:19273826-Magnetic Resonance Imaging, pubmed-meshheading:19273826-Male, pubmed-meshheading:19273826-Plasminogen Activators, pubmed-meshheading:19273826-Prospective Studies, pubmed-meshheading:19273826-Regression Analysis, pubmed-meshheading:19273826-Stroke, pubmed-meshheading:19273826-Tissue Plasminogen Activator, pubmed-meshheading:19273826-Tomography, X-Ray Computed, pubmed-meshheading:19273826-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
pubmed:affiliation
Department of Neurology, Radiology, and Centre for Clinical Epidemiology and Biostatistics, John Hunter Hospital/Hunter Medical Research Institute, University of Newcastle, Australia. mark.parsons@hnehealth.nsw.gov.au
pubmed:publicationType
Journal Article, Clinical Trial